| ovarian | R Documentation |
Survival in a randomised trial comparing two treatments for ovarian cancer
ovarian
| futime: | survival or censoring time |
| fustat: | censoring status |
| age: | in years |
| resid.ds: | residual disease present (1=no,2=yes) |
| rx: | treatment group |
| ecog.ps: | ECOG performance status (1 is better, see reference) |
Terry Therneau
Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979.